Imetelstat Sodium Patent Expiration
Imetelstat Sodium was first introduced by Geron Corp
Imetelstat Sodium Patents
Given below is the list of patents protecting Imetelstat Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Rytelo | US7494982 | Modified oligonucleotides for telomerase inhibition | Dec 27, 2025 | Geron |
| Rytelo | US9375485 | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms | Mar 15, 2033 | Geron |
| Rytelo | US9388415 | Modified oligonucleotides for telomerase inhibition | Sep 09, 2024 | Geron |
| Rytelo | US9388416 | Modified oligonucleotides for telomerase inhibition | Sep 09, 2024 | Geron |